10-year

10-Year Anniversary Promotion (20% off)

Join GuruFocus Premium Membership Now for Only $279/Year

Once a decade discount

Save up to $500 on Global Membership.

Don't Miss It !

Free 7-day Trial
All Articles and Columns »

Weekly Three-Year Low Highlights: QUNR, CGG, LADR, RARE

May 20, 2014 | About:
gurujx

gurujx

1 followers

According to GuruFocus list of three-year lows; Qunar Cayman Islands Ltd, CGG, Ladder Capital Corp. and Ultragenyx Pharmaceutical Inc. have all reached their three-year lows.

Qunar Cayman Islands Ltd. (QUNR) Reached the Three-Year Low of $21.25

The prices of Qunar Cayman Islands Ltd. (QUNR) shares have declined to close to the three-year low of $21.25, which is 42.4% off the three-year high of $36.73.

Qunar Cayman Islands Ltd. has a market cap of $2.42 billion; its shares were traded at around $21.25.

Quanar reported first quarter 2014 total revenue of $54 million and net loss per share of $0.03.

2 Gurus Initiated Positions: Frank Sands (Trades, Portfolio) bought 225,000 shares in the quarter that ended on 03/31/2014, which is 0.018% of the $38.38 billion portfolio of Sands Capital Management. Ron Baron (Trades, Portfolio) bought 211,147 shares in the quarter that ended on 12/31/2013, which is 0.023% of the $24.55 billion portfolio of Baron Funds. 1 Guru

2 Gurus Sold Out QUNR: Robert Karr (Trades, Portfolio) sold out his holdings in the quarter that ended on 03/31/2014. John Burbank (Trades, Portfolio) sold out his holdings in the quarter that ended on 03/31/2014.

CGG (CGG) Reached the Three-Year Low of $13.17

The prices of CGG (CGG) shares have declined to close to the three-year low of $13.17, which is 65.7% off the three-year high of $38.09.

CGG was established on July 23, 1931 to develop and market geophysical techniques for appraising underground geological resources. CGG has a market cap of $2.33 billion; its shares were traded at around $13.17 with and P/S ratio of 0.60. CGG had an annual average earnings growth of 2.30% over the past 10 years.

CGG has announced its first quarter 2014 results. Revenues were $806 million compared to $871 million a year ago. First quarter EBITDA decreased to $188 million from $272 million a year ago. Operating income was $35 million compared to $117 million last year.

Ladder Capital Corp (LADR) Reached the Three-Year Low of $17.11

The prices of Ladder Capital Corp (LADR) shares have declined to close to the 3-year low of $17.11, which is 16.5% off the three-year high of $19.77.

Ladder Capital Corp has a market cap of $1.7 billion; its shares were traded at around $17.11 with a P/E ratio of 41.90 and P/S ratio of 3.20.

The company has recently released its first quarter 2014 results ended March 31, 2014. Core earnings were $57.2 million compared to $94.4 million a year ago. Core EPS were $0.37, and the company has total equity of $1.43 billion, an increase of $245.6 million over the prior quarter.

Ultragenyx Pharmaceutical Inc. (RARE) Reached the Three-Year Low of $33.63

The prices of Ultragenyx Pharmaceutical Inc (RARE) shares have declined to close to the three-year low of $33.63, which is 53.2% off the three-year high of $69.77.

Ultragenyx Pharmaceutical Inc. has a market cap of $1.01 billion; its shares were traded at around $33.63.

Ultragenyx reported first quarter 2014 net loss of $18.4 million ($0.85 per diluted share) compared with a net loss of $8.2 million ($2.84 per share) a year ago.

Go here for the complete list of three-year lows.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK